Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid
Page last updated: 2024-10-21

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Catatonic Rigidity

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with Catatonic Rigidity in 2 studies

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid: structure given in first source; NMDA receptor antagonist

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klockgether, T1
Turski, L1
Shinozaki, H1
Ishida, M1
Goto, Y1

Other Studies

2 other studies available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and Catatonic Rigidity

ArticleYear
NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats.
    Annals of neurology, 1990, Volume: 28, Issue:4

    Topics: Animals; Dizocilpine Maleate; Drug Synergism; Electromyography; Levodopa; Male; Methyltyrosines; Mot

1990
Depression of decerebrate rigidity in the rat by antagonists of excitatory amino acids.
    Neuropharmacology, 1989, Volume: 28, Issue:6

    Topics: Amino Acids; Animals; Anticonvulsants; Azepines; Blood Pressure; Decerebrate State; Dibenzocyclohept

1989